A new metabolite contributing to N -acetyl signal in 1H MRS of the brain in Salla disease
Authors:
- 1 May 1999
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 52 (8) , 1668
Abstract
Objective: To determine whether N-acetylaspartate (NAA) is reduced in patients with Salla disease, a neurodegenerative disorder. Background: 1H MRS allows the brain metabolism to be studied noninvasively in vivo. N-acetyl (NA) is composed primarily of NAA, which is regarded as a neuronal marker. The NA signal in 1H MRS is reduced in several neurodegenerative disorders. Increased NA signal has thus far only been found in Canavan’s disease as a result of NAA accumulation in the brain tissue. In Salla disease, an autosomal recessive free sialic acid storage disorder, N-acetylneuraminic acid (NANA), accumulates in lysosomes of brain tissue. Methods: The authors studied eight patients with Salla disease (age range, 6 to 44 years) and eight age-matched healthy volunteers using quantitative 1H MRS. The spectra were obtained from two selected 8-cm3 volumes of interest localized in the basal ganglia and in the parietal white matter using conventional 1.5-T MRI equipment. The spectral resonance lines of NA groups, creatine and phosphocreatine (Cr), and choline-containing compounds (Cho) were analyzed quantitatively. All MR images were evaluated to verify the state of myelination. Results:1H MRS from parietal white matter revealed 34% higher NA and 47% higher Cr concentrations, and a 35% lower Cho concentration in the patients with Salla disease compared with the age-matched control subjects. The patients had a 22% higher water content in their parietal white matter, whereas in the basal ganglia the water concentrations did not differ significantly. In the patients’ basal ganglia the Cr concentration was 53% higher. Conclusions: NAA is considered to be a neuronal marker that, except for Canavan’s disease, has been found or assumed to be either stable or reduced. However, in Salla disease the high NA signal may have a contribution from accumulated lysosomal NANA, which offsets the possible loss of NAA. The high Cr is in line with the increased glucose uptake found in our earlier 2-fluoro-2-deoxy-D-glucose-PET study, reflecting increased energy demand. It is worth noting that in a conventional 1H MRS ratio-based analysis these underlying abnormalities would have remained undetected. Our study thus emphasizes the importance of a quantitative assessment of metabolite concentrations in 1H MRS for detecting altered brain metabolism.Keywords
This publication has 26 references indexed in Scilit:
- Salla disease ‐ rare or underdiagnosed?Developmental Medicine & Child Neurology, 1997
- Disorders of the Cerebral White Matter in Children. The Spectrum of LesionsNeuropediatrics, 1996
- Localized Proton Magnetic Resonance Spectroscopy of Cerebral Metabolic Disturbances in Children with Neuronal Ceroid LipofuscinosisNeuropediatrics, 1996
- Localized Proton Magnetic Resonance Spectroscopy of Cerebral MetabolitesNeuropediatrics, 1996
- Localized proton NMR spectroscopy in the striatum of patients with idiopathic parkinson's disease: a multicenter pilot studyMagnetic Resonance in Medicine, 1995
- Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolitesNMR in Biomedicine, 1994
- Phenotypic Variation and Magnetic Resonance Imaging (MRI) in Salla Disease, a Free Sialic Acid Storage DisorderNeuropediatrics, 1994
- Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlationsMagnetic Resonance in Medicine, 1994
- Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo‐inositol and related metabolitesNMR in Biomedicine, 1991
- Immunohistochemical localization of N-acetylaspartate in rat brainNeuroReport, 1991